Covovax Trials Begin in India, Hope to Launch it by Sept 2021: Adar Poonawalla

Serum Institute of India (SII) CEO Adar Poonawalla on Saturday said clinical trials of COVID-19 vaccine Covovax have begun in India and the company hopes to launch it by September this year. In August 2020, American vaccine company Novavax, Inc had announced a licence agreement with SII for the development and commercialisation of NVX-CoV2373, its COVID-19 vaccine candidate, in low and middle-income countries and India.

”Covovax trials finally begin in India; the vaccine is made through a partnership with @[email protected] has been tested against African and UK variants of #COVID19 and has an overall efficacy of 89%. Hope to launch by September 2021!,” Poonawalla said in a tweet.

Leave a Comment

Your email address will not be published. Required fields are marked *